HU900222D0 - Process for giving 5b-10, 45rh-103 isotops to ferrofluidic ferric oxide, advantageous stopping vital functions of cancerous cells - Google Patents
Process for giving 5b-10, 45rh-103 isotops to ferrofluidic ferric oxide, advantageous stopping vital functions of cancerous cellsInfo
- Publication number
- HU900222D0 HU900222D0 HU90222A HU22290A HU900222D0 HU 900222 D0 HU900222 D0 HU 900222D0 HU 90222 A HU90222 A HU 90222A HU 22290 A HU22290 A HU 22290A HU 900222 D0 HU900222 D0 HU 900222D0
- Authority
- HU
- Hungary
- Prior art keywords
- iron oxide
- isotope
- fine grain
- carrier medium
- grain iron
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
- A61K51/1244—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nanotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention refers to a method of preparing an iron oxide composition and an iron oxide composition for therapeutic treatment of a living body. The method comprises the steps of providing fine grain iron oxide, introducing the fine grain iron oxide into a liquid carrier medium applicable for therapeutic purposes and dispersing the fine grain iron oxide in the liquid carrier medium, including the novel step of completing the fine grain iron oxide with at least one isotope of low activity for a period sufficient for introducing the fine grain iron oxide into an organ targeted of the living body or at least one isotope capable of being activated by neutrons and decaying after the period or transforming under influence of the neutrons to a high activity isotope of short life time before transforming into a stable isotope. The composition as proposed comprises a liquid carrier medium, the liquid carrier medium being applicable in a living body and fine grain iron oxide made of at least one iron oxide selected from the group consisted of ferrous oxide, ferric oxide and ferroferric oxide forming a dispersion in the liquid carrier medium, wherein the fine grain iron oxide constitutes a solid carrier medium for bearing at least one isotope of low activity for a period sufficient for introducing the fine grain iron oxide into an organ targeted of the living body or at least one isotope capable of being activated by neutrons and decaying after the period or transforming under influence of the neutrons to an isotope of short life time radiating with high activity before transforming into a stable isotope, the stable isotope being not toxic.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU90222A HU900222D0 (en) | 1990-01-22 | 1990-01-22 | Process for giving 5b-10, 45rh-103 isotops to ferrofluidic ferric oxide, advantageous stopping vital functions of cancerous cells |
AU54234/90A AU5423490A (en) | 1990-01-22 | 1990-04-11 | Improved method of preparing an iron oxide composition for therapeutic treatment of a living body and iron oxide composition |
PCT/HU1990/000024 WO1991010452A1 (en) | 1990-01-22 | 1990-04-11 | Improved method of preparing an iron oxide composition for therapeutic treatment of a living body and iron oxide composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU90222A HU900222D0 (en) | 1990-01-22 | 1990-01-22 | Process for giving 5b-10, 45rh-103 isotops to ferrofluidic ferric oxide, advantageous stopping vital functions of cancerous cells |
Publications (1)
Publication Number | Publication Date |
---|---|
HU900222D0 true HU900222D0 (en) | 1990-04-28 |
Family
ID=10948558
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU90222A HU900222D0 (en) | 1990-01-22 | 1990-01-22 | Process for giving 5b-10, 45rh-103 isotops to ferrofluidic ferric oxide, advantageous stopping vital functions of cancerous cells |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU5423490A (en) |
HU (1) | HU900222D0 (en) |
WO (1) | WO1991010452A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5061476A (en) * | 1989-12-27 | 1991-10-29 | The Dow Chemical Company | Radiolabeled colloid compositions and method for preparing same |
RU1837891C (en) * | 1991-01-31 | 1993-08-30 | Keshelava Viktor V | Method for preparation antitumor agent |
CA2080978A1 (en) * | 1992-01-02 | 1993-07-03 | Hans-Jurgen F. Sinn | Retainer for a combined surgical needle shield with a needle tip stop feature |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4057616A (en) * | 1973-06-11 | 1977-11-08 | Mallinckrodt, Inc. | Metal hydroxide scintigraphic agents and method of preparation |
US4303636A (en) * | 1974-08-20 | 1981-12-01 | Gordon Robert T | Cancer treatment |
US4071613A (en) * | 1976-02-26 | 1978-01-31 | Abbott Laboratories | Stabilized alcohol solution of reducing salt formulations for use in preparing radioisotope labeled scanning agents: liver scanning technetium-99m colloid and method of preparation |
US4752464A (en) * | 1985-06-07 | 1988-06-21 | Cadema Medical Products, Inc. | Treatment of arthritis, including rheumatoid arthritis, with radioactive isotopes |
-
1990
- 1990-01-22 HU HU90222A patent/HU900222D0/en unknown
- 1990-04-11 AU AU54234/90A patent/AU5423490A/en not_active Abandoned
- 1990-04-11 WO PCT/HU1990/000024 patent/WO1991010452A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU5423490A (en) | 1991-08-05 |
WO1991010452A1 (en) | 1991-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL144559A0 (en) | Antibodies for cancer therapy and diagnosis | |
DK0683665T3 (en) | Magnetically reactive composition as carrier for biologically active substances as well as methods for its preparation and use | |
AU663266B2 (en) | Method for treating tumours | |
IL87885A0 (en) | Compounds having antiprogestational and anti-estrogenic activities for the treatment of tumours | |
CA2346644A1 (en) | Method for preventing xenograft transplant rejection using photodynamic therapy | |
EP0711300A4 (en) | 2-pyridylmethylenepolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents | |
EP0355307A3 (en) | Extraction agent for poly-d(-)-3-hydroxybutyric acid | |
SG46496A1 (en) | Tricyclopolyazamacrocyclophosphonic acids complexes and derivatives thereof for use as constrast agents | |
CA2133316A1 (en) | In vitro generation of human dendritic cells and uses thereof | |
ES8201316A1 (en) | Process for preparing lipoid-biologically active particles | |
EP1037531A4 (en) | Method of treatment of pigmented cancer cells utilizing photodynamic therapy | |
EP0719150A4 (en) | Cellular vaccine and methods of use for the treatment of solid tumor malignancies | |
CA2132001A1 (en) | Methods of treating cancer using modified c-reactive protein | |
AU7655300A (en) | Radiation source for endovascular radiation treatment in form of a wire | |
JPS57117868A (en) | Method of combining biological active substance to carrier containing hydroxyl group | |
HU900222D0 (en) | Process for giving 5b-10, 45rh-103 isotops to ferrofluidic ferric oxide, advantageous stopping vital functions of cancerous cells | |
CA2194485A1 (en) | Endothelial lining effects and treatment of vasospastic disorders | |
HUT55642A (en) | Process for producing surface therapy system containing antineoplasmatic agent expediently 5-fluoro-uracil | |
CA2327439A1 (en) | Combination therapy for the treatment of tumors | |
EP0248217A3 (en) | Treatment of tumors with autologous lak cells, interleukin-2 and an ornithine decarboxylase inhibitor | |
JPS5420193A (en) | Immobilized aminoacylase and its preparation | |
JPS5221203A (en) | Carbon-contained iron-base sintered alloy | |
JPS5257390A (en) | Immobilized enzyme and method of preparing the same | |
JPS52138431A (en) | Heat treatment of magnetic alloy of rare earths-cobalt line | |
DE3485282D1 (en) | COMPOSITION FOR TREATING BOUGIC TUMORS, ESPECIALLY IN ANIMALS. |